168 related articles for article (PubMed ID: 2158911)
1. [The significance of cGMP and dopamine receptor on the natriuretic and hypotensive activities of synthetic atrial natriuretic polypeptide in essential hypertension].
Mori K; Shigetomi S; Kohno H; Tosaki H; Kato K; Tanaka K; Haga H; Kin S; Fukuchi S
Nihon Naibunpi Gakkai Zasshi; 1990 Feb; 66(2):83-93. PubMed ID: 2158911
[TBL] [Abstract][Full Text] [Related]
2. [The significance of atrial natriuretic polypeptide in the cause of essential hypertension].
Mori K
Nihon Naibunpi Gakkai Zasshi; 1991 Jul; 67(7):796-810. PubMed ID: 1653713
[TBL] [Abstract][Full Text] [Related]
3. [The effects of the acute administration of atrial natriuretic peptide on the mechanisms regulating diuresis and natriuresis in the essential hypertension patient].
Iannettone CM; Strazzulla G; Fabbri G; Piazza E; Valenza T; De Feo ML; Franchi F
Ann Ital Med Int; 1991; 6(3):273-83. PubMed ID: 1837999
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular, renal and endocrine effects of alpha-human atrial natriuretic peptide in patients with Cushing's syndrome and primary aldosteronism.
Fujio N; Ohashi M; Nawata H; Kato K; Matsuo H; Ibayashi H
J Hypertens; 1989 Aug; 7(8):653-9. PubMed ID: 2553806
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular, endocrine and renal effects of atrial natriuretic peptide in essential hypertension.
Weidmann P; Gnädinger MP; Ziswiler HR; Shaw S; Bachmann C; Rascher W; Uehlinger DE; Hasler L; Reubi FC
J Hypertens Suppl; 1986 Jun; 4(2):S71-83. PubMed ID: 2941546
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the renin-aldosterone system and atrial natriuretic polypeptide in rats.
Hirata Y; Ishii M; Sugimoto T; Matsuoka H; Ishimitsu T; Atarashi K; Sugimoto T; Miyata A; Kangawa K; Matsuo H
Clin Sci (Lond); 1987 Feb; 72(2):165-70. PubMed ID: 2949908
[TBL] [Abstract][Full Text] [Related]
7. Pressure-dependent, enhanced natriuretic response to low-dose, atrial natriuretic peptide infusion in essential hypertension.
Eiskjaer H; Nielsen CB; Pedersen EB
J Intern Med; 1994 Dec; 236(6):665-74. PubMed ID: 7989902
[TBL] [Abstract][Full Text] [Related]
8. Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension.
Cusson JR; Hamet P; Gutkowska J; Kuchel O; Genest J; Cantin M; Larochelle P
J Hypertens; 1987 Aug; 5(4):435-43. PubMed ID: 2822796
[TBL] [Abstract][Full Text] [Related]
9. Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake.
Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Joyce SL; Gilchrist NL
J Clin Endocrinol Metab; 1986 Oct; 63(4):946-53. PubMed ID: 2943757
[TBL] [Abstract][Full Text] [Related]
10. Alpha-human atrial natriuretic polypeptide-induced rise of plasma and urinary cyclic 3'5'-guanosine monophosphate concentration in human subjects.
Ohashi M; Fujio N; Nawata H; Kato K; Ibayashi H
Clin Exp Hypertens A; 1986; 8(1):67-73. PubMed ID: 3011321
[TBL] [Abstract][Full Text] [Related]
11. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
Wambach G; Schittenhelm U; Bönner G; Kaufmann W
Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
[TBL] [Abstract][Full Text] [Related]
12. The effects of intravenous injection of alpha-human atrial natriuretic polypeptide on blood pressure, renal hemodynamics and urinary kinin excretion in anesthetized rabbits.
Nushiro N; Abe K; Seino M; Omata K; Yoshinaga K
Tohoku J Exp Med; 1987 Feb; 151(2):221-31. PubMed ID: 2953089
[TBL] [Abstract][Full Text] [Related]
13. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
[TBL] [Abstract][Full Text] [Related]
14. Alpha-human atrial natriuretic polypeptide reduces the plasma arginine vasopressin concentration in human subjects.
Fujio N; Ohashi M; Nawata H; Kato K; Ibayashi H; Kangawa K; Matsuo H
Clin Endocrinol (Oxf); 1986 Aug; 25(2):181-7. PubMed ID: 3024877
[TBL] [Abstract][Full Text] [Related]
15. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man.
Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Livesey JH
J Clin Endocrinol Metab; 1987 Oct; 65(4):765-72. PubMed ID: 2821056
[TBL] [Abstract][Full Text] [Related]
16. Natriuretic action of ANP is blunted by ACE inhibition in humans.
Wambach G; Schittenhelm U; Stimpel M; Bönner G; Kaufmann W
J Cardiovasc Pharmacol; 1989 May; 13(5):748-53. PubMed ID: 2472523
[TBL] [Abstract][Full Text] [Related]
17. Natriuretic and hypotensive effects of alpha-human atrial natriuretic polypeptide in anaesthetized DOCA-salt hypertensive rats.
Kondo K; Kida O; Kangawa K; Matsuo H; Tanaka K
Clin Exp Pharmacol Physiol; 1986 Feb; 13(2):97-101. PubMed ID: 2940041
[TBL] [Abstract][Full Text] [Related]
18. [Effects of phenylephrine on atrial natriuretic factor and the renin-aldosterone axis in normal patients and essential hypertensive patients].
Closas J; Genest J; Larochelle P; Cusson J; Gutkowska J; Hamet P; De Léan A; Thibault G; Cantin M
Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():75-8. PubMed ID: 2847676
[TBL] [Abstract][Full Text] [Related]
19. Evidence for an involvement of dopamine receptors in the natriuretic response to atrial natriuretic peptide.
Marin-Grez M; Angchanpen P; Gambaro G; Schnermann J; Schubert G; Briggs JP
Klin Wochenschr; 1987; 65 Suppl 8():97-102. PubMed ID: 2955166
[TBL] [Abstract][Full Text] [Related]
20. Intranasal application of atrial natriuretic peptide and 1-deamino-d-arginine vasopressin in healthy volunteers. Hemodynamic, hormonal, and renal excretory effects.
Predel HG; Kuklinski P; Kramer HJ
Am J Hypertens; 1992 Sep; 5(9):657-60. PubMed ID: 1329853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
